miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 ExpressionChifumi Ohyagi-Hara, Tadashi Kimura, Kenjiro Sawada et al.|American Journal Of Pathology|2013Cited by 96
Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the OvaryTakeshi Hisamatsu, Tadashi Kimura, Kenjiro Sawada et al.|Molecular Cancer Therapeutics|2013Cited by 41
The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the OvarySeiji Mabuchi, Tadashi Kimura, Takeshi Hisamatsu et al.|Clinical Cancer Research|2011Cited by 37
Data from The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the OvarySeiji Mabuchi, Tadashi Kimura, Takeshi Hisamatsu et al.|Unknown|2023Cited by 0
Data from Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the OvaryTakeshi Hisamatsu, Tadashi Kimura, Seiji Mabuchi et al.|Unknown|2023Cited by 0